Integra LifeSciences Cuts 2026 Guidance After Cincinnati Plant Flooding
Integra LifeSciences Holdings Corporation (NASDAQ:IART) reduced its full-year 2026 financial outlook following an operational disruption caused by flooding at its Cincinnati facility. The company now expects 2026 total revenue to range between $1.634 billion and $1.654 billion, while adjusted earnings per share are projected to land between $2.30 and $2.40.
The facility flood is expected to create a direct financial hit of $15 million to $20 million on fourth-quarter revenue. The unexpected update triggered a sharp market reaction, sending the stock down roughly 20% during intraday trading before shares partially recovered to $13.06. Most recently, the shares traded at $13.44.
Investors will monitor how effectively the company repairs its Cincinnati plant and manages fourth-quarter sales impacts. Future trading will depend on whether Integra LifeSciences can stabilize production and meet its updated full-year guidance targets.
Key points
- Integra LifeSciences cut its 2026 revenue guidance to between $1.634 billion and $1.654 billion.
- Adjusted earnings per share for 2026 are now expected to be between $2.30 and $2.40.
- Flooding at the Cincinnati facility is projected to reduce fourth-quarter revenue by $15 million to $20 million.
- Shares plunged about 20% intraday following the news before making a partial recovery to $13.06.
Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org
How we writeDisclaimerQuestions and answers
Why did Integra LifeSciences cut its 2026 financial guidance?
Integra LifeSciences lowered its outlook due to plant flooding in Cincinnati, which is expected to reduce fourth-quarter revenue by $15 million to $20 million.
What is Integra LifeSciences updated 2026 revenue and EPS outlook?
The company expects 2026 total revenue between $1.634 billion and $1.654 billion, with adjusted earnings per share projected at $2.30 to $2.40.
How did IART stock react to the guidance reduction?
IART stock dropped approximately 20% during intraday trading before making a partial recovery to trade near $13.06.
